chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started peeing out blood. It was pink.; had chills; low fever; fatigue; urine was a strange color; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EB8735) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. On 18Nov2020, the patient underwent lab tests and investigations that included PCR test for COVID-19 (Nasal Swab) and tested negative. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 17:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 15:00, the next day the patient's urine was a strange color, until the following day on 21Apr2021, the patient started peeing out blood which was pink. The patient reported that she was being tested for urinary tract infection (UTI) but did not have any UTI symptoms. On 20Apr2021 at 15:00, the day after the vaccine, the patient experienced chills, low fever and fatigue but on 21Apr2021, the patient had fully recovered. As of 22Apr2021, there was still blood in the urine. The patient reported that she had no history of any health concerns. On 21Apr2021, the patient underwent lab tests and investigations that included unspecified lab test for UTI and the results were unknown. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the reported events. The clinical outcome of the events chills, low fever and fatigue was recovered on 21Apr2021 while the outcome of the events urine was a strange color and blood in urine was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Large erythematic area (9cm x 20cm) on (R) upper lateral arm. Treated with 7 days of LEVAQUIN 500mg. Too follow in one week or sooner if necessary.
Lump at the injection site; Redness at the injection site; Tenderness at the injection site; Right Achilles tendon began to hurt; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 15:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included reactive airway disease, allergic to certain trees, weeds, grasses, molds, rodents and cats. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 within 30 minutes of receiving the vaccine, the patient's right achilles tendon began to hurt and it never hurt before in her life. On 01Apr2021 approximately 15 hours after receiving the vaccine, the patient experienced redness, tenderness and lump at the injection site which persisted 48 hours after the injection. The patient received ibuprofen and ice packs as a treatment for the event right achilles tendon hurt. The patient did not receive any treatment for the events redness, tenderness and lump at the injection site. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event right achilles tendon hurt was recovered on 02Apr2021, while that of lump at the injection site, redness at the injection site and tenderness at the injection site was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Erythema to right thigh starting on 10/12/17 following immunizations. TYLENOL and ibuprofen as needed fever/pain. Ice 15 minutes 4 x per day. Return in 2 days if symptoms worsen.
Sore, swollen, itchy and red arm just below vaccine site. Warm and hard to touch.
Case number PHEH2013US013521, is a combined initial and follow-up spontaneous report received from a nurse on 19 Jun 2013 and from nurse manager on 21 Jun 2013. This report refers to a 19-year-old male patient. He received only Men C, Y, W-135 liquid conjugate component of MENVEO vaccine (batch number: X11082 and expiry date: 01 Jun 2014), intramuscular without being reconstituted with Men A component on 05 Jun 2013. After that again he was vaccinated with complete dose of MENVEO on an unspecified date. No adverse reaction was reported following this administration error.
Patient presented to clinic w/ shortness of breath, widespread aching, and feverish, tingling in hands and feet 3 days after receiving flu vaccine.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (route of administration, lot # and expiration date not reported). There were no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Granuloma Annulare got slightly worse....had outbreak of new spots and some worsened/became larger. Mainly on hands.
Reported arm soreness and headache after being administered the COVID 19 vaccine; Reported arm soreness and headache after being administered the COVID 19 vaccine; This is a spontaneous report from a non-contactable Physician via Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine. On an unspecified date, the patient experienced arm soreness and headache after being administered the vaccine. Clinical outcome of the arm soreness and headache was unknown.     No follow-up attempts are possible. Information about batch number cannot be obtained.
Swollen bottom lip; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 15May2021 at 10:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and outside allergies. No concomitant medications were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16May2021 at 22:00, the patient experienced swollen bottom lip. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event swollen bottom lip was recovered on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
The patient did not recieve 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (The patient did not recieve 2nd dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (The patient did not recieve 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (The patient did not recieve 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was unknown.
2 weeks after receiving my first Moderna I experienced an alarmingly heavy period. It came a week early, in my 20 years of menstruating I?ve never experienced this heavy of a flow.  I normally use light tampons and it?s rarely fully saturated after 6 hours, I was bleeding through supers within a few hours. There is a zero chance of pregnancy so it wasn?t a miscarriage.
Patient had pericarditis after the 2nd dose of the Pfizer-BioNtech Covid-19 vaccine. He had chest pains 24 hours after the vaccine and so he went to ER where he was diagnosed with pericarditis (mild heart attack). He received treatment
My symptoms began about 4 days after the injection and continue to today. After the initial soreness in my right arm at the injection site, my upper arm muscles became extremely sore the following day and continued for 4 days. Muscle soreness continued in my upper arm and also moved to my lower arm.  It?s difficult to use my arm when trying to do anything that requires strength.  It also aches even when at rest or when holding my arm bent at the elbow as in driving or when typing on my iPad.  Occasionally, I get shooting pain through my upper arm. My doctor suggested a week ago, that I try Voltaren Gel and heat, so I am trying those but no relief so far.  In addition, my left shoulder muscles between by shoulder and my neck have been sore - similar to the feeling that excessive exercise might cause, however, I have not done any shoulder exercises.  I?m now at about 8 weeks since my 2nd vaccine and I am still suffering from this pain.
gigantic local rxn w/some fever p/4th dose;stayed off work 1 day;working on cow w/rabies;
Pt developed a mobilliform rash and fever to 101, 10 days after the vaccine
This is a spontaneous report from a contactable physician reported for male (patient). A male patient of an unspecified age received bnt162b2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration on an unspecified date as dose 1 single for covid-19 immunisation. Caller was a physician calling about the Covid 19 series of shots, the first 2. He called about the vaccine in general and mentioned a patient. This was the report for that one patient. Patient was unknown, caller stated it was a report he heard on a radio talk show. Caller stated it was even reported yesterday on the talk show about the shot series in LA, the host on the talk show who didn't represent anyone, he was a lawyer on the show for 3-4 years. Caller states he found out when the host had the second shot, on an unspecified date, he couldn't move for almost a whole day, he was lethargic, sick, nauseous and had a whole bunch of very bad effects. Caller stated when the reporter on radio couldn't move after the second shot and stayed in bed all day. Caller stated both were not talking about that. Outcome of the event was unknown.
Muscles and joint pain. Slight fever. Nauseous. Immediately and still on going
Systemic: Dizziness / Lightheadness-Severe, Systemic: Shakiness-Mild, Additional Details: her boyfriend says she faints easily
Client reports has a hive below where shot was given. Client reports hive is 1 inch by 2 inches, slightly itches.  Referred to follow-up with PCP regarding hive. Client reports has called her physician and was referred to call local health department to have VAERS completed.
Four to six hours after receiving the Covid booster in my left arm very near my acromion process I developed severe pain and could not extend my left arm outward from my body without using my other arm to support it.  I have never been given an injection so high up on the shoulder!  I phoned the pharmacy to complain to the pharmacist and told her I was an RN and that her technique was off.  It needs to be two to three finger breadths below the acromion process.  I have been using ice, ibuprofen, Voltarin topical to ease the pain.  This feels like frozen shoulder.
4/9&10/08-Headache, fever, aches.  4/24/08 Rash erupted.  4/27/08-Headache, sore throat.
Within about 24 ours after receiving the seasonal flu vaccine I began to feel that I was getting ill - deep fatigue and what felt like the early symptoms of a cold or flu. No temperature elevation, but was knocked out and spent 2 days in bed.
Patient was accidentally given GARDASIL 9 instead of PCV 13. She did experience a "low grade fever," and vomiting x1 on the afternoon of the vaccination. Her symptoms self resolved without treatment.
Information has been received from a health professional concerning a 6 year old female who on 27 JAN 1999 was vaccinated with one dose of variella virus vaccine live (site unknown) (lot # unknown). Subsequently, it was reported that on 14 MAY 2001 the patient was diagnosed with a mild case of chicken pox. Unspecified medical attention was sought. It was reported that in the Spring of 2001, there was a very large chicken pox outbreak in the area. It was not specified whether or not the patient had an exposure to these cases. The reporter also indicated that the vaccine was not given close to the expiration date and that the vaccine lot numbers were not similar in the other cases reported. Subsequently the patient recovered. No further information is available.
Date of Admission: 3/22/2023 Discharge Date: 3/25/2023   PRESENTING PROBLEM: Weakness  Generalized weakness  COVID    HOSPITAL COURSE: Patient is an 80 year old female recently admitted for syncope and discharged to SAR, she was diagnosed with Covid on 3/20, developed diarrhea and weakness, she was noted to be out of rehab days, and was sent to ED for evaluation.  Patient was noted to have significant weakness, having difficulty standing and ambulating.  Laboratories in the emergency department did reconfirm COVID infection, there were no other signs of infection.  The hospitalist team was consulted for admission for possible placement.  Patient did not have any significant diarrhea during admission.  Her vital signs remained stable.  His discussion with the patient's daughter with her case management team, they did not want to pay any copays for further rehab.  They decided to take her home with home health care, RN, PT, OT.  At this time the patient is medically stable for discharge to her daughter's house with home healthcare.   Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
102 plus fever next day, flu like symptoms Swollen lymph nodes under the arm, painful and sore
On the day of vaccination my arm was sore but at night i had a fever, chills, muscle aches and headache associated with insomnia. Symptoms started to get worse the next day of vaccination as I was hardly moving my left arm and i had to get off work early because i couldn't stand on my feet for a long time. finally on the third day symptoms started to improve.
fainted right after taking the vaccine; This is a spontaneous report from a non-contactable consumer (Pfizer company representative).  A female patient of an unspecified age received the bnt162b2 (BNT162B2; also reported as COVID-19 vaccine; Batch/lot number, NDC number, Expiry Date: Unknown), via an unspecified route of administration on 17Dec2020 at a single dose for COVID-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced fainted right after taking the vaccine (medically significant) on 17Dec2020. It was unknown if the patient received other products, and any investigation assessment was unknown. The clinical course was reported as follows: The reporter stated they had seen quite a bit on social media and on the (site name), where people have been sending around a video regarding a healthcare worker who fainted. The caller was just wondering " if Pfizer has been made aware of this. "Apparently, this was on the news. This healthcare worker was taking the COVID-19 vaccine and as she was talking to the press, she apparently fainted. It looks as if she fainted as one would do when taking blood tests or faint from fear of a shot or being worried. However, this video has been sent all over social media, as seen as an AE, and telling people to not take the vaccine." The reporter further clarified the healthcare worker was in (city name) and received the COVID-19 vaccine. As the healthcare worker was talking to the press, she fainted right after taking the vaccine. The reporter further clarified she was sent a link via (site name) from the news channel where it had the video recording. The reporter did not have a specific reporter. The reporter explained it was a " whole group that was talking about it." The reporter clarified she was in a (state name) group on (site name) with friends and family. The reporter also saw it on social media. " People are sending it left and right." When probed to determine if the reporter had any patient details or further details regarding the event, the caller stated the only information she had was that on (News name), and click on (City name) news and find the video of the healthcare worker taking the vaccine and fainting. The reporter clarified the news article was dated as 17Dec2020 "so this event must have happened yesterday." From the reporter's understanding from the news, the patient was fine, she got up.  "However, people are sending out on social media that she is dead", which the reporter did not think was the outcome. According to the news, when the reporter opened the link, it was just a regular fainting, it was not a death.  The reporter felt obligated to report and make sure Pfizer was aware of this since she had been seeing it everywhere on social media. The clinical outcome of the event, fainted right after taking the vaccine, was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Mother calling re son, 3 years old, who received Flumist at Health depart on Friday. A little more than 48 hrs later he developed a fever. She called Flu info line and was told this could be a side effect of the vaccine. Today he has developed a harsh cough. He is not eating much, drinking a little. His pull-ups are damp but not heavy with urine. She thought at one point his breathing was labored but as he was sleeping in her arms she said his breathing was easy- no distress, no inspiratory noise, no intercostal retractions. Past hx of seasonal allergies- (she has a nebulizer and albuterol)  but denies history of wheezing or asthma.  On 11/11/2009 Contacted mother for followup  Mother states that it 'was a pretty rough week' for patient. He developed a fever of 104.8 with the cough. She presented to the pediatrician and he diagnosed H1N1 infection clinically (no nasal swabs since he had received the Flu Mist vaccine). He was  treated with a course of Tamiflu and recovered without incident. Mother states that he is feeling well today.
Caller stated that she received her first vaccine on 4/11/2021 and on 4/13/2021 she developed hives round her waist and they're not going away and now they're spread all over her body.
Hallucinations (auditory).  no treatment.  sent to psychiatry.  continue 3 times since the vaccination.  last episode 10/12/21.
Fussy - shaky - parents described as twitching site soreness at (R) and (L) thigh ax temp 1003.
pt recv vax 15APR96 & 19APR96 pt devel a vesicular rash, followed by a fulminant case of chickenpox on 22APR96;tx w/atarax, APAP, Ibuprofen & emollient;pt recovered;
6/15/08: Office visit: patient came in for swollen arm due to immunization.  MD notes: moderate swelling with erythema and tenderness, about 15 x 7 cm area around vaccination site of left upper arm.  Patient/parent instruction given by MD: Can take Motrin every 6 hours to help with pain for a day or so.
Vaccination failure; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 70-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 23Sep2023 as dose 1, single (Lot number: HG4629) at the age of 70 years, in left arm for covid-19 immunisation; for covid-19 immunisation. The patient's relevant medical history included: "Parkinsons" (unspecified if ongoing); "Atrial fibrillation" (unspecified if ongoing). Concomitant medication(s) included: SINEMET, start date: 03Sep2022; ELIQUIS, start date: 10Jan2023. Vaccination history included: bnt162b2 (DOSE 1, SINGLE Lot no. EL9265 on Left arm), administration date: 05Feb2021, when the patient was 67-year-old, for Covid-19 Immunization; bnt162b2 (DOSE 2, SINGLE Lot no. EN6200 on Left arm), administration date: 01Mar2021, when the patient was 67-year-old, for Covid-19 Immunization; bnt162b2 (DOSE 3 (BOOSTER), SINGLE Lot no. FF8839 on Left arm), administration date: 15Oct2021, when the patient was 68-year-old, for Covid-19 Immunization; bnt162b2 (DOSE 4 (BOOSTER), SINGLE Lot no. FK9896 on Left arm), administration date: 06Apr2022, when the patient was 68-year-old, for Covid-19 Immunization; bnt162b2;bnt162b2 omi ba.4-5 (DOSE 5 (BOOSTER), SINGLE Lot no. GH9697 on Left arm), administration date: 24Oct2022, when the patient was 69-year-old, for Covid-19 Immunization. The following information was reported: COVID-19 (medically significant) with onset 22Oct2023, outcome "unknown"; VACCINATION FAILURE (medically significant) with onset 22Oct2023, outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22Oct2023) Positive; (30Oct2023) Positive; (01Nov2023) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19, Paxlovid was administered from 23Oct2023 to 28Oct2023. No follow-up attempts are possible. No further information is expected. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.